List view / Grid view
The European Antibody Congress is returning to the city of Basel for its 14th year on the 29-31 October 2018, and here is everything you need to know about our biggest event yet...
Researchers at the University of Florida have discovered that a modified version of an important immune cell protein, TLR5, could be used to treat Alzheimer's disease.
Many biopharmaceutical companies look to produce biosimilars soon, since the patents on the original mAb expire over the next few years...
Hormones that signal the body's state of hunger and fullness could be the key to new treatments for drug and alcohol addiction...
There are no short-cuts in the complex field of lipidomics, explains Cristina Legido-Quigley, a Principal Investigator in Systems Medicine at Steno Diabetes Center Copenhagen in Denmark and at King’s College London.
Scientists have discovered that itaconate - a molecule derived from glucose - acts as a powerful off-switch for macrophages...
Researchers have uncovered a way to treat aggressive tumours through manipulation of the connective tissue cells of the tumour.
An international team of scientists has developed a water-soluble “warped nanographene”, a flexible molecule that is biocompatible and shows promise for fluorescent cell imaging.
Corning to unveil new product offerings at Cell & Gene Therapy World in Miami, Fla.
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and found a compound that stops the disease in its tracks.
A new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer's disease by stopping toxic ion flow in the brain...
Are selective, brain-penetrant inhibitors of LRRK2 an answer?
A debate on the impact of PFS regulation at Pre-Filled Syringes 2018...
A synthetic double-stranded RNA has potential for use as an anti-liver cancer vaccine...
Focused laser beam could help scientists map connections among neurons that underlie behaviour...
